OTCMKTS:THCBF - THC Biomed Intl Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.22
  • Forecasted Upside: 162.84 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$0.08
+0.30 (1.20%)

This chart shows the closing price for THCBF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New THC Biomed Intl Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for THCBF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for THCBF

Analyst Price Target is $0.22
▲ +162.84% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for THC Biomed Intl in the last 3 months. The average price target is $0.22, with a high forecast of $0.22 and a low forecast of $0.22. The average price target represents a 162.84% upside from the last price of $0.08.

This chart shows the closing price for THCBF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 investment analysts is to buy stock in THC Biomed Intl.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/11/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/11/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/9/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/7/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/5/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/6/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/5/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/4/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
1/28/2021Fundamental ResearchInitiated CoverageBuy$0.22
(Data available from 8/5/2016 forward)
THC Biomed Intl logo
THC Biomed Intl Ltd. produces and sells medical and recreational cannabis in Canada. The company conducts research and development of products and services related to the medical cannabis industry. It also offers cannabis beverage under the THC KISS brand name, as well as pure cannabis sticks. The company was founded in 2012 and is headquartered in Kelowna, Canada.
Read More

Today's Range

Now: $0.08
Low: $0.08
High: $0.08

50 Day Range

MA: $0.10
Low: $0.08
High: $0.11

52 Week Range

Now: $0.08
Low: $0.06
High: $0.27

Volume

2,975 shs

Average Volume

93,688 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of THC Biomed Intl?

The following equities research analysts have issued research reports on THC Biomed Intl in the last year: Fundamental Research.
View the latest analyst ratings for THCBF.

What is the current price target for THC Biomed Intl?

1 Wall Street analysts have set twelve-month price targets for THC Biomed Intl in the last year. Their average twelve-month price target is $0.22, suggesting a possible upside of 162.8%. Fundamental Research has the highest price target set, predicting THCBF will reach $0.22 in the next twelve months. Fundamental Research has the lowest price target set, forecasting a price of $0.22 for THC Biomed Intl in the next year.
View the latest price targets for THCBF.

What is the current consensus analyst rating for THC Biomed Intl?

THC Biomed Intl currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe THCBF will outperform the market and that investors should add to their positions of THC Biomed Intl.
View the latest ratings for THCBF.

What other companies compete with THC Biomed Intl?

How do I contact THC Biomed Intl's investor relations team?

The company's listed phone number is (844) 842-6337. The official website for THC Biomed Intl is thcbiomed.com.